Attwa, M. W., Kadi, A. A., Abdelhameed, A. S., & Alhazmi, H. A. (2020). Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC–MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies. Drug Des Devel Ther.
Citação norma ChicagoAttwa, Mohamed W., Adnan A. Kadi, Ali S. Abdelhameed, and Hassan A. Alhazmi. "Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC–MS/MS Methodology: In Silico Metabolic Vulnerability and Toxicity Studies." Drug Des Devel Ther 2020.
MLA引文Attwa, Mohamed W., Adnan A. Kadi, Ali S. Abdelhameed, and Hassan A. Alhazmi. "Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC–MS/MS Methodology: In Silico Metabolic Vulnerability and Toxicity Studies." Drug Des Devel Ther 2020.